Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)

This article is a response-to-comments document regarding Minimally Invasive Glaucoma Surgery (MIGS) and does not itself define specific coverage indications, limitations, documentation requirements, or frequency limits. The content appears to address stakeholder comments rather than establish benefit criteria; manual review of the full responses is recommended to determine whether any substantive coverage decisions are embedded in the document.